| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 32 | 123 | 9.8K |
2 | Health Sciences | 17 | 46 | 3K |
3 | Public Health | 14 | 29 | 4.2K |
4 | Engineering | 2 | 2 | 34 |
5 | Education | 1 | 4 | 76 |
Hospital Mãe de Deus
×
1.1K
Publications
27K
Citations
| Year | Citations | |
|---|---|---|
2009 | 547 | |
2014 | 497 | |
2013 | 496 | |
2014 | 420 | |
2002 | 388 | |
2021 | 366 | |
2011 | 258 | |
2017 | 257 | |
2018 | 254 | |
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial Mikhail Kosiborod, Russell Esterline, Remo H.M. Furtado, The Lancet Diabetes & Endocrinology Cardiovascular DiseaseCardiometabolic RiskCardiovascular PharmacologyRiskCardiometabolic Risk Factors | 2021 | 235 |
Page 1
Page 1